is ozempic a glp-1 Drug Can Cause Rare, Potentially Blinding Side Effect, EMA Warns Is GLP-1 the Same as
Description
Treatment with liraglutide and a lipidized analog of prolactin-releasing peptide (Palm11-PrRP31) exerts neuroprotective effects in APP/PS1 mice
Note that the costs, dosages, and approved uses are U.S.-based
EVOO also slowed early gastric emptying -- the same mechanism that GLP-1 drugs exploit to promote fullness
Thus, new anti-obesity treatments are needed
In addition, there are new and innovative molecule types in the obesity pipeline, including monoclonal antibodies, antibody-drug conjugates, nanoparticle-drug conjugates, peptides, radiopharmaceuticals, recombinant proteins, and gene therapies, among others
